NCPA: Competitive bidding could limit patient access

July 31, 2006

Millions of Medicare beneficiaries would face decreased access to DME such as wheelchairs and diabetes test strips if a proposed rule by CMS takes effect, according to NCPA. The association issued a statement saying "the so-called Competitive Acquisition Program developed by CMS creates huge administrative burdens for pharmacists that could affect the availability of DME, prosthetics, orthotics, and supplies, as well as Medicare Part B medications, immunizations, therapeutic shoes, diabetes supplies, and nebulizers.

NCPA: Competitive bidding could limit patient access

Millions of Medicare beneficiaries would face decreased access to DME such as wheelchairs and diabetes test strips if a proposed rule by CMS takes effect, according to NCPA. The association issued a statement saying "the so-called Competitive Acquisition Program developed by CMS creates huge administrative burdens for pharmacists that could affect the availability of DME, prosthetics, orthotics, and supplies, as well as Medicare Part B medications, immunizations, therapeutic shoes, diabetes supplies, and nebulizers. The proposed rule would require pharmacists to obtain additional accreditation and submit to a competitive bidding process in order to continue to sell these essential supplies to Medicare beneficiaries beginning in 2007." NCPA has submitted comments to CMS.

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.